Clinical Trials for Osteoporosis

Clinical trials study osteoporosis, an often preventable metabolic bone disease.  Osteoporosis is characterized by low bone density that contributes to vertebral compression fractures (VCFs).  Vertebral compression fractures occur when one or more spinal vertebral bodies break or collapse.
laboratory technician working with multiwell pipette
Research studies lead to better diagnostic tests that detect and manage osteoporosis, development of drugs that slow bone loss, and improved minimally invasive surgical treatment of painful vertebral compression fractures.

Perhaps you are interested in learning about clinical trials for osteoporosis and/or vertebral compression fractures.  If so, please continue reading.

Maybe your doctor has talked to you about preventing the onset or progression of osteoporosis.  Possibly, you take a medication to control osteoporosis and reduce your risk of spinal fracture.  Some patients come to learn that a clinical trial may be a way to receive treatment by a specialist.

About Clinical Trials for Osteoporosis and Vertebral Compression Fractures

Enrollment in a clinical trial for osteoporosis and/or vertebral compression fracture is not automatic.  Rather, the clinical trial investigator (eg, leading physician) or study conductor follow a strict protocol—that’s the study’s plan.  The plan outlines every aspect of the study, including the patient selection process, how therapy is administered, frequency of post-therapy evaluations, and trial duration. 

The clinical trial investigator may be a board certified and fellowship trained specialist, such as a primary care doctor, orthopaedic spine surgeon, physiatrist, or endocrinologist.  The study coordinator may be an advanced practice nurse experienced working with patients diagnosed with osteoporosis, or those who have undergone surgical treatment of vertebral compression fractures.  Depending on the size of the clinical trial (number of patients and trial locations), several investigators and coordinators may be involved.  

Participant safety is a primary concern.  Therefore, many safeguards are built into a clinical trial protocol.  The purpose of a clinical study is to evaluate the safety of a drug, device, or therapy.  The end goal is to improve care for patients with osteoporosis and vertebral compression fractures.